This transcript highlights the successful deployment and validation of an automated workflow system, referred to as the "Avenue wedge," for preparing circulating tumor DNA (ctDNA) libraries. After a swift one-week installation and training period, verification runs demonstrated high concordance between manual preparation and the automated process. The system has since processed over 200 ctDNA samples from a collaborator since July 2022. Due to the extremely small quantity of ctDNA per sample, only one library preparation attempt is feasible, making the system's proven reliability critical. This has led to strong confidence in utilizing the Avenue system for all future ctDNA projects.
Summary of the Transcript:
0:05 System Implementation: The automated system was installed and initial training completed within a single week.
0:12 High Concordance Achieved: Verification samples were run, and analysis by external collaborators showed a high concordance between results from manual preparation and the new automated workflow.
0:23 Extensive Sample Processing: Since July 2022, over 200 circulating tumor DNA (ctDNA) samples have been successfully processed in collaboration with a partner.
0:37 Criticality of Sample Volume: The amount of ctDNA available per sample is extremely small, meaning there is only one opportunity to run the ctDNA on the library preparation system.
0:47 Confidence in Avenue Wedge Reliability: The reliability of the Avenue wedge system has instilled significant confidence, ensuring successful processing of these critical, limited ctDNA samples.
0:54 Future Project Assurance: The successful track record provides strong assurance for using the Avenue system in all future ctDNA projects.